Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8613 |
High Similarity |
NPD3027 |
Phase 3 |
0.8406 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8298 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8298 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8273 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8156 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8085 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7943 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7892 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7892 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7875 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.784 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7799 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7793 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7786 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7786 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7786 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.777 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7761 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7746 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD228 |
Approved |
0.7733 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7714 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD37 |
Approved |
0.7683 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7655 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7609 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7595 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7593 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7562 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7562 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7562 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7535 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7535 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD8252 |
Approved |
0.747 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7463 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7463 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7438 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7425 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7417 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7417 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7405 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7368 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7346 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7337 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7329 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7303 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7278 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7244 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7233 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7215 |
Intermediate Similarity |
NPD1512 |
Approved |
0.72 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7197 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7193 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD7472 |
Approved |
0.717 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7117 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7115 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7107 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD846 |
Approved |
0.7068 |
Intermediate Similarity |
NPD940 |
Approved |
0.7067 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7052 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.705 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7044 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7037 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7034 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7032 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7032 |
Intermediate Similarity |
NPD5763 |
Approved |
0.703 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7027 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7027 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7021 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7021 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7013 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7466 |
Approved |
0.6994 |
Remote Similarity |
NPD5089 |
Approved |
0.6994 |
Remote Similarity |
NPD5090 |
Approved |
0.6994 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6992 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6987 |
Remote Similarity |
NPD7037 |
Approved |
0.6987 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD1240 |
Approved |
0.6968 |
Remote Similarity |
NPD5408 |
Approved |
0.6968 |
Remote Similarity |
NPD5406 |
Approved |
0.6968 |
Remote Similarity |
NPD5404 |
Approved |
0.6968 |
Remote Similarity |
NPD5405 |
Approved |
0.6964 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6962 |
Remote Similarity |
NPD5241 |
Discontinued |
0.6959 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD5451 |
Approved |
0.6954 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6954 |
Remote Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD1651 |
Approved |
0.6944 |
Remote Similarity |
NPD5691 |
Approved |
0.6943 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6943 |
Remote Similarity |
NPD3060 |
Approved |
0.6941 |
Remote Similarity |
NPD2489 |
Approved |
0.6941 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD27 |
Approved |
0.6939 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6937 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD4675 |
Approved |
0.6933 |
Remote Similarity |
NPD4678 |
Approved |
0.6929 |
Remote Similarity |
NPD7635 |
Approved |
0.6923 |
Remote Similarity |
NPD3051 |
Approved |
0.6923 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6918 |
Remote Similarity |
NPD3092 |
Approved |
0.6914 |
Remote Similarity |
NPD4578 |
Approved |
0.6914 |
Remote Similarity |
NPD7310 |
Approved |
0.6914 |
Remote Similarity |
NPD7311 |
Approved |
0.6914 |
Remote Similarity |
NPD7312 |
Approved |
0.6914 |
Remote Similarity |
NPD7313 |
Approved |
0.6914 |
Remote Similarity |
NPD8313 |
Approved |
0.6914 |
Remote Similarity |
NPD4577 |
Approved |
0.6914 |
Remote Similarity |
NPD8312 |
Approved |
0.6909 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.6905 |
Remote Similarity |
NPD5494 |
Approved |
0.6903 |
Remote Similarity |
NPD3748 |
Approved |
0.6903 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD5846 |
Approved |
0.6893 |
Remote Similarity |
NPD4663 |
Approved |
0.6892 |
Remote Similarity |
NPD1283 |
Approved |
0.6886 |
Remote Similarity |
NPD3749 |
Approved |
0.6886
|
Remote Similarity |
NPD7075 |
Discontinued |